Mandate

Stora Enso increases its holding in Cellutech

October 29, 2018 M&A

Vinge has advised Cellutech in connection with the minority shareholder Stora Enso acquiring all shares in the company.

Cellutech was founded in 2013 and consists of an active team with eight scientists and researchers who act as a link between academia and industry.

Cellutech was started in order to develop ideas from high class technology research at SweTree Technologies and Wallenberg Wood Science Center to commercially successful technology and products.

Vinge’s team consisted of Johan Winnerblad and Kristina Ekberg.
 

Related

Vinge has advised Vicore Pharma Holding AB (publ) in connection with its rights issue

Vinge has advised Vicore Pharma Holding AB (publ) in connection with an oversubscribed rights issue of shares whereby Vicore receives issue proceeds of approximately SEK 782 million before deduction of transaction costs.
October 22, 2024

Vinge has advised Vicore Pharma Holding AB (publ) in connection with its directed share issue

Vinge has advised Vicore Pharma Holding AB (publ) in connection with a directed share issue, whereby Vicore receives issue proceeds of approximately SEK 100 million before deduction of transaction costs.
October 22, 2024

Vinge has advised the Swedish state in connection with the reconstruction proceedings of SAS

Vinge has advised the Swedish state in connection with the reconstruction proceedings of SAS. The proceedings, which included considerations regarding state aid approved by the European Commission, have among other things involved restructuring, debt write-downs as well as an investment by a consortium consisting of Castlelake, Air France-KLM, Lind Invest and the Danish state. In total, the investment amounted to approximately USD 1.2 billion in SAS, divided into USD 475 million in unlisted equity and USD 725 million in convertible debt.
October 21, 2024